Center MM, Jemal A, Ward E. International trends in colorectal cancer incidence rates. Cancer Epidemiol Biomark Prev. 2009;18(6):1688–94.
Xi Y, Xu P. Global colorectal cancer burden in 2020 and projections to 2040. Trans Oncol. 2021;14(10):101174.
Jemal A, Bray F, Center MM, Ferlay J, Ward E, Forman D. Global cancer statistics. CA: Cancer J Clin. 2011;61(2):69–90.
Siegel EM, Jacobsen PB, Lee J-H, Malafa M, Fulp W, Fletcher M, et al. Florida initiative for quality cancer care: improvements on colorectal cancer quality of care indicators during a 3-year interval. J Am Coll Surg. 2014;218(1):16-25e4.
Liu W, Zhang X, Xu H, Li S, Lau HC-H, Chen Q, et al. Microbial community heterogeneity within colorectal neoplasia and its correlation with colorectal carcinogenesis. Gastroenterology. 2021;160(7):2395–408.
Article CAS PubMed Google Scholar
Anghel SA, Ioniță-Mîndrican C-B, Luca I, Pop AL. Promising epigenetic biomarkers for the early detection of colorectal cancer: a systematic review. Cancers. 2021;13(19):4965.
Article CAS PubMed PubMed Central Google Scholar
Sepich-Poore GD, Zitvogel L, Straussman R, Hasty J, Wargo JA, Knight R. The microbiome and human cancer. Science. 2021;371(6536):eabc4552.
Article CAS PubMed PubMed Central Google Scholar
Chu Y, Sun S, Huang Y, Gao Q, Xie X, Wang P, et al. Metagenomic analysis revealed the potential role of gut microbiome in gout. npj Biofilms Microb. 2021;7(1):1–13.
Tripathi VP, Goo D, Maidya BN, Aneebuddin M. New trends in interrelation of infectious colorectal cancer with intestinal microbiota. Arch Gastroenterol Res. 2022;3(1):18–22.
Li R, Shen J, Xu Y. Fusobacterium nucleatum and colorectal cancer. Infect Drug Resist. 2022;15:1115.
Article CAS PubMed PubMed Central Google Scholar
Mira-Pascual L, Cabrera-Rubio R, Ocon S, Costales P, Parra A, Suarez A, et al. Microbial mucosal colonic shifts associated with the development of colorectal cancer reveal the presence of different bacterial and archaeal biomarkers. J Gastroenterol. 2015;50(2):167–79.
Article CAS PubMed Google Scholar
Slade DJ. New roles for Fusobacterium nucleatum in cancer: target the bacteria, host, or both? Trends Cancer. 2021;7(3):185–7.
Article CAS PubMed Google Scholar
Gur C, Ibrahim Y, Isaacson B, Yamin R, Abed J, Gamliel M, et al. Binding of the Fap2 protein of Fusobacterium nucleatum to human inhibitory receptor TIGIT protects tumors from immune cell attack. Immunity. 2015;42(2):344–55.
Article CAS PubMed PubMed Central Google Scholar
Wu Z, Ma Q, Guo Y, You F. The role of Fusobacterium nucleatum in colorectal cancer cell proliferation and migration. Cancers. 2022;14(21):5350.
Article CAS PubMed PubMed Central Google Scholar
Ghafouri-Fard S, Hussen BM, Badrlou E, Abak A, Taheri M. MicroRNAs as important contributors in the pathogenesis of colorectal cancer. Biomed Pharmacother. 2021;140:111759.
Article CAS PubMed Google Scholar
Hussen BM, Hidayat HJ, Salihi A, Sabir DK, Taheri M, Ghafouri-Fard S. MicroRNA: a signature for cancer progression. Biomed Pharmacother. 2021;138:111528.
Article CAS PubMed Google Scholar
Hsieh P, Yamane K. DNA mismatch repair: molecular mechanism, cancer, and ageing. Mech Ageing Dev. 2008;129(7–8):391–407.
Article CAS PubMed PubMed Central Google Scholar
Uzuner E, Ulu GT, Gürler SB, Baran Y. The role of MiRNA in cancer: pathogenesis, diagnosis, and treatment. miRNomics: Springer; 2022. p. 375–422.
Bitaraf A, Razmara E, Bakhshinejad B, Yousefi H, Vatanmakanian M, Garshasbi M, et al. The oncogenic and tumor suppressive roles of RNA-binding proteins in human cancers. J Cell Physiol. 2021;236(9):6200–24.
Article CAS PubMed Google Scholar
Liu T, Liu D, Guan S, Dong M. Diagnostic role of circulating MiR-21 in colorectal cancer: a update meta-analysis. Ann Med. 2021;53(1):87–102.
Article CAS PubMed Google Scholar
Niu L, Yang W, Duan L, Wang X, Li Y, Xu C, et al. Biological implications and clinical potential of metastasis-related miRNA in colorectal cancer. Mol Ther-Nucleic Acids. 2021;23:42–54.
Article CAS PubMed Google Scholar
Zhang W, Jiang Z, Tang D. The value of exosome-derived noncoding RNAs in colorectal cancer proliferation, metastasis, and clinical applications. Clin Transl Oncol. 2022;24(12):2305–18.
Article CAS PubMed Google Scholar
Fu F, Jiang W, Zhou L, Chen Z. Circulating exosomal miR-17-5p and miR-92a-3p predict pathologic stage and grade of colorectal cancer. Transl Oncol. 2018;11(2):221–32.
Article PubMed PubMed Central Google Scholar
Gao Y, Han T, Han C, Sun H, Yang X, Zhang D, et al. Propofol regulates the TLR4/NF-κB pathway through miRNA-155 to protect colorectal cancer intestinal barrier. Inflammation. 2021;44(5):2078–90.
Article CAS PubMed Google Scholar
Zhang Y, Zhang L, Zheng S, Li M, Xu C, Jia D, et al. Fusobacterium nucleatum promotes colorectal cancer cells adhesion to endothelial cells and facilitates extravasation and metastasis by inducing ALPK1/NF-κB/ICAM1 axis. Gut Microb. 2022;14(1):2038852.
Bakshi HA, Quinn GA, Nasef MM, Mishra V, Aljabali AA, El-Tanani M, et al. Crocin inhibits angiogenesis and metastasis in colon cancer via TNF-α/NF-kB/VEGF pathways. Cells. 2022;11(9):1502.
Article CAS PubMed PubMed Central Google Scholar
Liu Y, Baba Y, Ishimoto T, Tsutsuki H, Zhang T, Nomoto D, et al. Fusobacterium nucleatum confers chemoresistance by modulating autophagy in oesophageal squamous cell carcinoma. Br J Cancer. 2021;124(5):963–74.
Article CAS PubMed Google Scholar
Hong J, Guo F, Lu S-Y, Shen C, Ma D, Zhang X, et al. F. nucleatum targets lncRNA ENO1-IT1 to promote glycolysis and oncogenesis in colorectal cancer. Gut. 2021;70(11):2123–37.
Article CAS PubMed Google Scholar
Shariati A, Razavi S, Ghaznavi-Rad E, Jahanbin B, Akbari A, Norzaee S, et al. Association between colorectal cancer and Fusobacterium nucleatum and Bacteroides fragilis bacteria in Iranian patients: a preliminary study. Infect Agents Cancer. 2021;16(1):1–10.
Komiya Y, Shimomura Y, Higurashi T, Sugi Y, Arimoto J, Umezawa S, et al. Patients with colorectal cancer have identical strains of Fusobacterium nucleatum in their colorectal cancer and oral cavity. Gut. 2019;68(7):1335–7.
Tunsjø HS, Gundersen G, Rangnes F, Noone JC, Endres A, Bemanian V. Detection of Fusobacterium nucleatum in stool and colonic tissues from Norwegian colorectal cancer patients. Eur J Clin Microbiol Infect Dis. 2019;38(7):1367–76.
Huang X, Zhu X, Yu Y, Zhu W, Jin L, Zhang X, et al. Dissecting miRNA signature in colorectal cancer progression and metastasis. Cancer Lett. 2021;501:66–82.
Article CAS PubMed Google Scholar
Dragomir MP, Knutsen E, Calin GA. Classical and noncanonical functions of miRNAs in cancers. Trends Genet. 2021;38(4):379–94.
Shibuya H, Iinuma H, Shimada R, Horiuchi A, Watanabe T. Clinicopathological and prognostic value of microRNA-21 and microRNA-155 in colorectal cancer. Oncology. 2010;79(3–4):313–20.
Article CAS PubMed Google Scholar
Nassar FJ, Msheik ZS, Itani MM, Helou RE, Hadla R, Kreidieh F, et al. Circulating mirna as biomarkers for colorectal cancer diagnosis and liver metastasis. Diagnostics. 2021;11(2):341.
Article CAS PubMed PubMed Central Google Scholar
Koopaie M, Abedinejad F, Manifar S, Mousavi R, Kolahdooz S, Shamshiri A. Salivary miRNA-21 expression as a potential non-invasive diagnostic biomarker in breast cancer. Gene Rep. 2021;25:101317.
Alexandre D, Teixeira B, Rico A, Valente S, Craveiro A, Baptista PV, et al. Molecular beacon for detection miRNA-21 as a biomarker of lung cancer. Int J Mol Sci. 2022;23(6):3330.
Article CAS PubMed PubMed Central Google Scholar
Ma S, Kong S, Gu X, Xu Y, Tao M, Shen L, et al. As a biomarker for gastric cancer, circPTPN22 regulates the progression of gastric cancer through the EMT pathway. Cancer Cell Int. 2021;21(1):1–14.
Huang C, Liu J, Xu L, Hu W, Wang J, Wang M, et al. MicroRNA-17 promotes cell proliferation and migration in human colorectal cancer by downregulating SIK1. Cancer Manage Res. 2019;11:3521.
留言 (0)